Insider · CIK 0001226231

ZAMBROWICZ BRIAN P

Reports to the SEC for 1 company · THE WOODLANDS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001226231

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+21.3K sh	—	—	255,389
2014-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+21.5K sh	—	—	276,889
2014-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+20K sh	—	—	296,889
2014-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−18.2K sh	$1.92	−$34.9K	278,703
2014-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	−21.3K sh	—	—	21,250
2014-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	−21.5K sh	—	—	43,000
2014-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	−20K sh	—	—	60,000
2014-02-06	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)A Award	EVP, Chief Scientific Officer	AAward	+85K sh	—	—	85,000
2014-02-06	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	EVP, Chief Scientific Officer	AAward	+340K sh	—	—	340,000
2013-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+21.3K sh	—	—	224,331
2013-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+21.5K sh	—	—	245,831
2013-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−11.7K sh	$1.98	−$23.2K	234,139
2013-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	−21.3K sh	—	—	42,500
2013-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	−21.5K sh	—	—	64,500
2013-02-08	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)A Award	EVP, Chief Scientific Officer	AAward	+80K sh	—	—	80,000
2013-02-08	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	EVP, Chief Scientific Officer	AAward	+320K sh	—	—	320,000
2013-01-31	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+42.1K sh	—	—	216,580
2013-01-31	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−13.5K sh	$2.11	−$28.5K	203,081
2013-01-31	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	−42.1K sh	—	—	0
2012-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+21.3K sh	—	—	180,101
2012-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−5,621 sh	$1.78	−$10K	174,480
2012-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	−21.3K sh	—	—	63,750
2012-02-15	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)A Award	EVP, Chief Scientific Officer	AAward	+86K sh	—	—	86,000
2012-02-15	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	EVP, Chief Scientific Officer	AAward	+344K sh	—	—	344,000
2011-02-23	LXRXLEXICON PHARMACEUTICALS, INC.A Award	EVP, Chief Scientific Officer	AAward	+26.2K sh	—	—	166,732
2011-02-23	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−7,881 sh	$1.81	−$14.3K	158,851
2011-02-23	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	EVP, Chief Scientific Officer	AAward	+340K sh	—	—	340,000
2011-02-23	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)A Award	EVP, Chief Scientific Officer	AAward	+85K sh	—	—	85,000
2010-02-15	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	EVP, Chief Scientific Officer	AAward	+450K sh	—	—	450,000
2010-02-15	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)A Award	EVP, Chief Scientific Officer	AAward	+42.1K sh	—	—	42,100
2010-02-12	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−9,011 sh	$1.91	−$17.2K	140,489
2009-08-12	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−7,300 sh	$1.30	−$9,490	149,500
2009-02-12	LXRXLEXICON PHARMACEUTICALS, INC.A Award	EVP, Chief Scientific Officer	AAward	+55.2K sh	—	—	156,800
2009-02-12	LXRXLEXICON PHARMACEUTICALS, INC. · Employee Stock Option (right to buy)A Award	EVP, Chief Scientific Officer	AAward	+450K sh	—	—	450,000
2007-02-01	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+90K sh	$1.67	+$150K	153,900
2007-02-01	LXRXLEXICON PHARMACEUTICALS, INC.S Sale	EVP, Chief Scientific Officer	SSale	−52.3K sh	$3.89	−$203K	101,600
2007-02-01	LXRXLEXICON PHARMACEUTICALS, INC. · Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	−90K sh	—	—	0
2005-02-18	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	EVP, Chief Scientific Officer	AAward	+70K sh	—	—	70,000

Recent filings

Accepted (ET)
Mar 34
LEXICON PHARMACEUTICALS, INC./DE0001127602-14-009653
SEC(opens sec.gov)
Feb 104
LEXICON PHARMACEUTICALS, INC./DE0001127602-14-005344
SEC(opens sec.gov)
Mar 14
ZAMBROWICZ BRIAN P0001127602-13-008831
SEC(opens sec.gov)
Feb 124
ZAMBROWICZ BRIAN P0001127602-13-005626
SEC(opens sec.gov)
Feb 44
ZAMBROWICZ BRIAN P0001127602-13-003953
SEC(opens sec.gov)
Mar 14
ZAMBROWICZ BRIAN P0001127602-12-008895
SEC(opens sec.gov)

Companies

LEXICON PHARMACEUTICALS, INC.EVP, Chief Scientific OfficerLXRX

Address

8800 TECHNOLOGY FOREST PLACE

THE WOODLANDS, TX, 773811160